Sheikh Sarah I
Senior Medical Director, Late Stage Clinical Development at Biogen, Cambridge, MA 02142, USA.
Neurodegener Dis Manag. 2018 Feb;8(1):13-15. doi: 10.2217/nmt-2017-0059. Epub 2018 Jan 31.
Sarah Isabel Sheikh speaks to Laura Dormer, Commissioning Editor: Sarah I Sheikh, MD, MSc, MRCP, is a Senior Medical Director in Late Stage Clinical Development at Biogen. Her current focus is on developing therapies for multiple sclerosis/neuroinflammation, remyelination and neuro-repair. Prior to Biogen, Dr Sheikh was an attending in Neurology at Brigham and Women's Hospital. She completed her internship at Massachusetts General Hospital and residency in Neurology and Neuromuscular fellowship at Massachusetts General Hospital and Brigham and Women's Hospital. She received her medical degree from Oxford University Medical School, and a Masters in cell physiology from Oxford University, Corpus Christi College. She is a member of the Royal College of Physicians, London.
莎拉·伊莎贝尔·谢赫与编辑主任劳拉·多尔默交谈：莎拉·伊·谢赫医学博士、理学硕士、皇家内科医师学会会员，是渤健公司晚期临床开发的高级医学总监。她目前专注于开发治疗多发性硬化症/神经炎症、髓鞘再生和神经修复的疗法。在加入渤健公司之前，谢赫博士是布莱根妇女医院的神经科主治医师。她在麻省总医院完成了实习，并在麻省总医院和布莱根妇女医院完成了神经科住院医师培训以及神经肌肉专科 fellowship。她毕业于牛津大学医学院，获得医学学位，并在牛津大学基督圣体学院获得细胞生理学硕士学位。她是伦敦皇家内科医师学会的成员。
